The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Urethral Stricture Treatment Devices Market Expected To Scale Between 2026 And 2030?
The urethral stricture treatment devices market has experienced significant growth over recent years. It is anticipated to increase from $1.47 billion in 2025 to $1.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.0%. The expansion observed historically can be attributed to several factors including an increase in urological disorders, the growing aging male population, the rise in catheterization procedures, the expansion of hospital urology departments, and developments in surgical stricture treatments.
The urethral stricture treatment devices market size is projected to experience substantial growth in the forthcoming years. This market is anticipated to reach $2.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. The expansion during the forecast period is driven by factors such as the rise in minimally invasive urology, the demand for long-term stent solutions, the adoption of advanced biomaterials, the growth of outpatient procedures, and personalized urology devices. Noteworthy trends for the forecast period include minimally invasive stricture management, advancements in balloon dilation technologies, advanced urethral stents, improved catheter materials, and outpatient urology procedures.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Urethral Stricture Treatment Devices Market Development?
The increasing incidence of benign prostatic hyperplasia (BPH) and neurogenic bladder is anticipated to propel the urethral stricture treatment devices market going forward. BPH is a common condition among older men, characterized by an enlarged prostate gland that frequently causes urinary obstruction and heightens the risk of urethral strictures. The rising prevalence of benign prostatic hyperplasia (BPH) is primarily influenced by aging, with a greater incidence in men over 50, while lifestyle, hormonal changes, and chronic conditions also contribute to its development. Urethral stricture treatment devices are commonly employed in urological conditions such as benign prostatic hyperplasia (BPH), particularly when post-surgical complications or extended catheterization lead to urethral narrowing, requiring interventions like dilators, stents, or urethrotomy tools to restore normal urinary flow. For instance, in September 2023, according to a report published by the Royal Pharmaceutical Society, a UK-based professional body, approximately 3 million people in the UK are affected by BPH, with its incidence being around 50% in males aged 60–70 years and rising to 90% in males aged over 80 years. Therefore, the rising prevalence of BPH and neurogenic bladder will drive the urethral stricture treatment device market.
What Are The Different Segment Types In The Urethral Stricture Treatment Devices Market Segment Breakdown?
The urethral stricture treatment devices market covered in this report is segmented –
1) By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, Urinary Catheters
2) By Stricture Location: Anterior, Posterior
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Urethral Dilators: Semi-Rigid Urethral Dilators, Flexible Urethral Dilators, Balloon Urethral Dilators, Graded Urethral Dilators
2) By Urethral Stents: Self-Expanding Urethral Stents, Balloon-Expandable Urethral Stents, Metallic Urethral Stents, Silicone Urethral Stents
3) By Urethral Balloon Dilation Catheters: Single-Balloon Dilation Catheters, Double-Balloon Dilation Catheters, Coaxial Balloon Dilation Catheters, Hydrophilic-Coated Balloon Dilation Catheters
4) By Urinary Catheters: Foley Urinary Catheters, Intermittent Urinary Catheters, External Urinary Catheters, Supra-Pubic Urinary Catheters
What Trends Are Transforming The Urethral Stricture Treatment Devices Market?
Leading companies in the urethral stricture treatment devices market are embracing strategic partnerships to improve technology integration and expand their market presence. A strategic partnership denotes a collaborative relationship where two or more organizations merge their resources, expertise, and efforts to achieve mutual goals. For example, in April 2024, Laborie Medical Technologies Corp., a US-based diagnostic and therapeutic medical technology firm, formed a partnership with the NHS Specialized Services Device Programme (SSDP) to incorporate its Optilume Urethral Drug-Coated Balloon (DCB) into the program. This alliance guarantees reimbursement for NHS hospitals in England, thus broadening patient access to this innovative device. Optilume integrates balloon dilation with anti-proliferative drug delivery to diminish the recurrence of urethral strictures. This minimally invasive technology offers a revolutionary alternative to conventional surgery or repetitive treatments, addressing a significant demand within the urology community.
Who Are The Well-Known Companies In The Urethral Stricture Treatment Devices Market?
Major companies operating in the urethral stricture treatment devices market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, Medline Industries LP., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun SE, Olympus Corporation, Coloplast Ltd, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, ConvaTec Inc., Ambu A/S, Richard Wolf GmbH, Laborie Medical Technologies, Bactiguard AB, UROMED Kurt Drews KG, Pnn Medical A/S, Hydrumedical SA, Allium Ltd., Med pro Medical B.V., Urotronic Inc., Rocamed SAM, Zhejiang ChuangXiang Medical Technology Co. Ltd
Get The Full Urethral Stricture Treatment Devices Market Report:
Which Region Leads The Urethral Stricture Treatment Devices Market In Terms Of Market Share?
North America was the largest region in the urethral stricture treatment devices market in 2025. The regions covered in the urethral stricture treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Urethral Stricture Treatment Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Urethral Stricture Treatment Devices Market 2026, By The Business Research Company
Bath And Shower Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/bath-and-shower-products-global-market-report
Urology Surgical Instruments Market Report 2026
https://www.thebusinessresearchcompany.com/report/urology-surgical-instruments-global-market-report
Urinary Stone Treatment Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model